OTC Markets Stock News
All posts tagged "biotech"
-
1.4KBiotechCanada started clinical treatment with bio-tech plasma to fight against covid-19
The world has this fight against COVID-19 because of its detrimental effects that can kill humans and destroy a nation’s economy. Canada...
-
21.3KBiotechTop Coronavirus Stocks backed by Scientific Evidence
Developing a vaccine to treat COVID-19 is hands down the best way to play the long term coronavirus stocks. Ultimately a vaccine...
-
21.8KBiotechInvestors Fleeing CytoDyn Missing the Golden Nugget from the BLA Delay
Sell first analyze later mentality of investors oblivious to the increased likelihood of a BLA approval may cost them handsome upside CytoDyn...
-
2.2KBiotechIs Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) A Risky ‘Buy’ Investment?
Trend reversal appears to be in play, as Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) continues to bounce back after plunging to all-time lows late last...
-
2.7KBiotechAntibe Therapeutics Inc (OTCMKTS:ATBPF): A Potential Acquisition Target
Antibe Therapeutics Inc (OTCMKTS:ATBPF) is enjoying one of its best runs in the market, thanks to a string of positive news that...
-
3.2KBiotechPropanc Biopharma Inc (OTCMKTS:PPCB) Is Due For A Rebound
The recent stock performance of Propanc Biopharma Inc (OTCMKTS:PPCB) has not fulfilled the expectations of the market. Over the past year, the...
-
1.4KBiotechGuided Therapeutics Inc (OTCBB:GTHP) Makes Progress In Its Fight Against Cervical Cancer
Guided Therapeutics Inc (OTCBB:GTHP) has become a beacon in the global fight against cancer. The firm has had to battle against declining...
-
2.1KBiotechUS Stem Cell Inc (OTCMKTS:USRM) Still A Nice Recovery Play As Stem Cell Demand Explodes
US Stem Cell Inc (OTCMKTS:USRM) has lived up to expectations as a nice recovery play. Investors who took time to read our...
-
1.4KBiotechRich Pharmaceuticals Inc (OTCMKTS:RCHA) is Relentless in its Bid to Overcome Cancer and Blood–Related Diseases
Rich Pharmaceuticals Inc (OTCMKTS:RCHA) is not in the best of places now. Since its peak of $0.0013 last year, it has been...
-
1.3KBiotechPivot Pharmaceuticals Inc (OTCMKTS:PVOTF) On A Comeback Trail After Acquisition Spree
After spiking to record highs of $2.46 a share, Pivot Pharmaceuticals Inc (OTCMKTS:PVOTF) immediately felt the wrath of short sellers who triggered...
